Clinical Trial Update: A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.

View source ↗

Summary

The clinical trial evaluating an optical blood pressure assessment tool to identify unscreened hypertension in an active U.S. population has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Nucor | Conditions: Hypertension | Status: WITHDRAWN